An Integrated Closed-loop Feedback System for Pediatric Cardiometabolic Disease (STRIVE)
Primary Purpose
Obesity, Health Behavior
Status
Unknown status
Phase
Early Phase 1
Locations
Study Type
Interventional
Intervention
mHealth wristband
mHealth scale
EMA
mHealth app
Health Behavior Feedback
Integrated closed-loop feedback system
Sponsored by

About this trial
This is an interventional prevention trial for Obesity focused on measuring cardiometabolic risk, obesity, mHealth, health behaviors
Eligibility Criteria
Inclusion Criteria:
- ages 6-12 years
- body mass index categorized as overweight or obese
- followed for obesity care
- an adult household family member with one or more elevated cardiometabolic risk, as defined by established or documented increased risk of cardiometabolic disease (overweight, obesity, hypertension, coronary artery disease, diabetes or glucose intolerance, dyslipidemia, non-alcoholic fatty liver disease, cerebrovascular disease)
- participating parent must own Android Smartphone
- Wi-Fi access at home
- speak and read English
Exclusion Criteria:
- n/a
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
intervention
control
Arm Description
Intervention subjects will receive feedback on their health behaviors along with clinical recommendations.
Control subjects will receive feedback on their health behaviors for self-guided care.
Outcomes
Primary Outcome Measures
BMI, Child
mean change in BMI z-score
Secondary Outcome Measures
Health Behaviors Index, Child and Adult
Cardiometabolic risk will be reported as an index score, a continuous variable calculated as the sum of Z-scores of mean daily moderate-to-vigorous physical activity (minutes), mean daily sleep (minutes), mean daily screen time (minutes), and mean weekly sugar sweetened beverage intake.
BMI, Adult
mean change in BMI z-score
Full Information
NCT ID
NCT02659163
First Posted
January 12, 2016
Last Updated
August 31, 2017
Sponsor
Massachusetts General Hospital
Collaborators
Massachusetts Institute of Technology
1. Study Identification
Unique Protocol Identification Number
NCT02659163
Brief Title
An Integrated Closed-loop Feedback System for Pediatric Cardiometabolic Disease
Acronym
STRIVE
Official Title
An Integrated Closed-loop Feedback System for Pediatric Cardiometabolic Disease
Study Type
Interventional
2. Study Status
Record Verification Date
August 2017
Overall Recruitment Status
Unknown status
Study Start Date
October 2017 (Anticipated)
Primary Completion Date
October 2018 (Anticipated)
Study Completion Date
October 2018 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Massachusetts General Hospital
Collaborators
Massachusetts Institute of Technology
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The high prevalence and burden of cardiometabolic disease underlie the urgent need to identify novel approaches to managing and preventing cardiometabolic disease and risk. This project will test an innovative use of mobile health technology to implement a closed-loop feedback system that collects objective patient-generated data and provides clinical recommendations to modify contributing health behaviors. In addition to improving care for cardiometabolic disease, the tools and methods developed by this study for collecting patient data and providing clinical feedback could also easily be adapted and applied to a range of other health conditions, and are thus highly relevant to public health.
Detailed Description
Cardiometabolic disease - a clustering of medical conditions and risk factors which includes obesity, diabetes, impaired liver function, and an increased risk in children for adult-onset cardiovascular disease - represents a major population-wide health burden in the United States. Management of cardiometabolic disease also imposes a substantial financial burden on the economy and ties up significant healthcare resources. It is well-known that many of the lifestyle and health behaviors that contribute to cardiometabolic disease are difficult to modify once established, and childhood represents an opportune time for promoting healthy behaviors. Patient-centered outcomes research (PCOR) has identified certain health behaviors as important and actionable in modifying cardiometabolic risk, namely weight management, physical activity, screen-time, sleep, and consumption of sugar-sweetened beverages. Mobile health technology (mHealth) could be used to monitor and counsel on common health behaviors associated with cardiometabolic risk, which may facilitate the inclusion of PCOR evidence on cardiometabolic disease into clinical practice. The overall goal of this research is to use mHealth technology to accelerate the uptake of PCOR findings on treatment of cardiometabolic disease. To achieve our goal, this study will develop a novel set of mHealth tools capable of collecting health behavior information and determine to what extent providing clinical feedback on these health behaviors improves obesity and health behaviors among children ages 6-12 year and their families. In this study we will develop, implement, and test the comparative clinical effectiveness of a closed-loop feedback system for collecting patient data and providing recommendations. The specific aims of this study are: 1) to develop an integrated closed-loop feedback system that incorporates longitudinal mHealth data in managing cardiometabolic disease among at-risk families, and 2) to determine the extent to which an integrated closed-loop system that provides feedback on objective patient-generated data improves cardiometabolic risk, as measured by changes in body mass index and health behaviors including, physical activity, screen-time, sleep, and sugar-sweetened beverage consumption. This research will develop novel mHealth tools and approaches that will allow healthcare providers and patients to better understand disease risk and improve disease management by collecting patient data 1) repeatedly over time, 2) simultaneously, and 3) objectively. This study is innovative because it will use mHealth tools to simultaneously collect longitudinal data on multiple health behaviors known to be associated with cardiometabolic risk, and it will offer a new approach to implementing and disseminating PCOR findings via a novel closed-loop feedback system. The high prevalence of cardiometabolic disease makes this innovative closed-loop system very relevant to public health. The mHealth tools and methods developed by this study for collecting patient data and providing clinical feedback could also easily be adapted and applied to a range of other health conditions.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity, Health Behavior
Keywords
cardiometabolic risk, obesity, mHealth, health behaviors
7. Study Design
Primary Purpose
Prevention
Study Phase
Early Phase 1
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
68 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
intervention
Arm Type
Experimental
Arm Description
Intervention subjects will receive feedback on their health behaviors along with clinical recommendations.
Arm Title
control
Arm Type
Active Comparator
Arm Description
Control subjects will receive feedback on their health behaviors for self-guided care.
Intervention Type
Behavioral
Intervention Name(s)
mHealth wristband
Other Intervention Name(s)
sensors
Intervention Description
A wristband containing several sensors worn by participants to collect daily objective patient-generated health behavior data on physical activity, sleep, and screen time
Intervention Type
Behavioral
Intervention Name(s)
mHealth scale
Other Intervention Name(s)
wireless sscale
Intervention Description
A wireless scale used by participants to measure and record daily weight.
Intervention Type
Behavioral
Intervention Name(s)
EMA
Other Intervention Name(s)
Sugar Sweetened Beverage Assessment
Intervention Description
Self-reported information on sugar sweetened beverage consumption collected via mobile messaging
Intervention Type
Behavioral
Intervention Name(s)
mHealth app
Intervention Description
A mobile application that houses study data and provides two-way messaging between the study team and study participants.
Intervention Type
Behavioral
Intervention Name(s)
Health Behavior Feedback
Intervention Description
Provide feedback on patient-generated health behaviors data, along with standard of care recommendations, for self-guided
Intervention Type
Behavioral
Intervention Name(s)
Integrated closed-loop feedback system
Intervention Description
Daily feedback and weekly e-report cards on patient-generated longitudinal health behaviors along with clinical recommendations via mobile messaging
Primary Outcome Measure Information:
Title
BMI, Child
Description
mean change in BMI z-score
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Health Behaviors Index, Child and Adult
Description
Cardiometabolic risk will be reported as an index score, a continuous variable calculated as the sum of Z-scores of mean daily moderate-to-vigorous physical activity (minutes), mean daily sleep (minutes), mean daily screen time (minutes), and mean weekly sugar sweetened beverage intake.
Time Frame
6 months
Title
BMI, Adult
Description
mean change in BMI z-score
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
6 Years
Maximum Age & Unit of Time
12 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
ages 6-12 years
body mass index categorized as overweight or obese
followed for obesity care
an adult household family member with one or more elevated cardiometabolic risk, as defined by established or documented increased risk of cardiometabolic disease (overweight, obesity, hypertension, coronary artery disease, diabetes or glucose intolerance, dyslipidemia, non-alcoholic fatty liver disease, cerebrovascular disease)
participating parent must own Android Smartphone
Wi-Fi access at home
speak and read English
Exclusion Criteria:
n/a
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Nicolas M Oreskovic, MD, MPH
Phone
617.726.0593
Email
noreskovic@mgh.harvard.edu
First Name & Middle Initial & Last Name or Official Title & Degree
John D Knutsen, PhD
Phone
617.726.6721
Email
jknutsen@mgh.harvard.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nicolas M Oreskovic, MD, MPH
Organizational Affiliation
Massachusetts General Hospital
Official's Role
Principal Investigator
12. IPD Sharing Statement
Links:
URL
https://projectreporter.nih.gov/project_info_description.cfm?aid=8904119&icde=27624918&ddparam=&ddvalue=&ddsub=&cr=2&csb=default&cs=ASC
Description
Related Info
Learn more about this trial
An Integrated Closed-loop Feedback System for Pediatric Cardiometabolic Disease
We'll reach out to this number within 24 hrs